Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 9k
20 July 2020
Question for written answer
to the Commission
Rule 138
Sirpa Pietikäinen (PPE)
 Subject: Using phages to prevent food-related listeria outbreaks

Listeria outbreaks killed or seriously damaged the health of around 1 000 Europeans in 2019 only. These food-related outbreaks can be prevented using phages like Listex P100, which is already being used in countries such as Canada, the US, Australia, New Zealand and Switzerland.

The Commission has made no decision on the use of phages in food to significantly reduce the threat of new listeria outbreaks. Given the proven safety and efficacy of Listex P100 in reducing the threat of a listeria outbreak, it should be made available in the European Union, as it is in the above-mentioned markets, either as a non-decontaminating processing aid and/or through a new phage regulation.

What concrete steps does the Commission intend to take to remedy the current unacceptable situation that is preventing this life-saving, safe and innovative product from being sold comercially?

Last updated: 31 July 2020Legal notice - Privacy policy